Since drafting Joel Embiid in 2014, the Philadelphia 76ers have heavily centered their team around him. However, Embiid’s career has been hampered by frequent injuries, limiting his availability and letting playoff hopes slip away. The 76ers recently signed LeBron James to a two-year, $8 million deal, a move that significantly reduces the team’s reliance on Embiid’s health and boosts their chances as contenders for the Eastern Conference title and their first NBA championship since 1983.

The offseason saw major organizational changes after the 76ers’ playoff loss to the New York Knicks. Managing partner Josh Harris replaced president of basketball operations Daryl Morey with Cleveland Cavaliers general manager Mike Gansey, who revamped the roster. Key acquisitions include All-NBA forward Jaylen Brown from the Celtics, plus veterans Dean Wade and Anfernee Simons, along with rookie guard Labaron Philon Jr., all bolstering the team’s depth and appeal to James.

LeBron James himself was uncertain about continuing his career after the Lakers’ playoff exit, even acknowledging he thought his career might be over. But the revamped 76ers lineup convinced him to return, reuniting with Gansey, a longtime acquaintance, and pairing with guard Tyrese Maxey, who’s also represented by James’s agent and workout partner Rich Paul. This fresh roster composition makes Philadelphia less dependent on Embiid, who has struggled to stay healthy despite his MVP form when on the court.

At 41, James remains a top-tier player and veteran leader, averaging impressive stats last season and playoffs. His presence lifts the 76ers beyond Embiid’s availability concerns. With Jaylen Brown and Tyrese Maxey both entering career-best forms and promising young talent like VJ Edgecombe rising, the 76ers are positioned strongly for deep playoff runs. James’s signing signals his prime motivation is winning, eyeing a historic fourth NBA title with a new franchise and giving Philadelphia renewed hope for overcoming past postseason disappointments.